MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis.
about
TGF-β/Smad signaling in renal fibrosisMini-review: emerging roles of microRNAs in the pathophysiology of renal diseasesMiRNAs in kidney transplantation: potential role as new biomarkers.miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1.MicroRNA-382 induced by HIF-1α is an angiogenic miR targeting the tumor suppressor phosphatase and tensin homolog.Intermittent exposure to xenon protects against gentamicin-induced nephrotoxicity.Characteristics of microRNAs enriched in specific cell types and primary tissue types in solid organsMicroRNAs in renal fibrosis.Translational study of microRNAs and its application in kidney disease and hypertension research.miR-21 contributes to xenon-conferred amelioration of renal ischemia-reperfusion injury in mice.Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes.Increased susceptibility to kidney injury by transfer of genomic segment from SHR onto Dahl S genetic background.The Expression of miR-192 and Its Significance in Diabetic Nephropathy Patients with Different Urine Albumin Creatinine Ratio.MicroRNAs contribute to the maintenance of cell-type-specific physiological characteristics: miR-192 targets Na+/K+-ATPase β1.Small molecules targeting microRNA for cancer therapy: Promises and obstacles.Renal Tumor Necrosis Factor α Contributes to Hypertension in Dahl Salt-Sensitive Rats.Meprin A metalloproteinase and its role in acute kidney injury.The regulation and function of microRNAs in kidney diseases.MicroRNA and nephropathy: emerging concepts.MicroRNA in situ hybridization for formalin fixed kidney tissues.Targeting kallikrein-related peptidases in prostate cancer.miR-21 contributes to renal protection by targeting prolyl hydroxylase domain protein 2 in delayed ischaemic preconditioning.MiR-146a/b: a family with shared seeds and different roots.Noncoding RNA and epigenetic gene regulation in renal diseases.Chronic Inhalation of E-Cigarette Vapor Containing Nicotine Disrupts Airway Barrier Function and Induces Systemic Inflammation and Multi-Organ Fibrosis in Mice.MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.Therapeutic potential of microRNAs for the treatment of renal fibrosis and CKD.MicroRNAs associated with the development of kidney diseases in humans and animals.Renal Delivery of Anti-microRNA Oligonucleotides in Rats.Tissue-specific effects of targeted mutation of Mir29b1 in rats
P2860
Q26851198-CDE1224E-8C15-41F3-9B0B-111A9133CE46Q28354033-76B8BCEC-5A21-442E-89CD-785B25A4C820Q30456341-B16790A3-65E8-45CF-ADB3-B78513280B7EQ33820023-24FF0C57-F263-4197-B57C-92529BCFB5C7Q33843200-65797A56-960D-499E-976B-B5EAA45B2589Q34758731-96E2DAAE-1F21-4BB0-93A1-E84996953838Q35004352-A00C16CB-5E06-4E88-BE84-D708119BC6DFQ35104478-79B71D19-4B38-4B96-92EB-BEEDD82B29A1Q35597051-062749F2-15FE-4472-B2E4-7FA52C61A0F5Q35597122-5F31230A-E07B-4EE1-AC2C-A534264ED902Q35973844-0FB8E13F-D8D5-41AC-838E-4351AC6A270FQ36185479-7A4A630D-803E-4828-AD0E-60A52056CB9FQ36530347-B40FE8CC-EA70-43F9-9768-1F87D1B77110Q36559204-FFB3348D-F1C4-4226-AD85-BDA9E053C06AQ36567511-FFB9F0E7-F4D2-4CB7-A85F-D41308884E4BQ36621305-F70916B1-7EEC-4AE5-9304-C4FDF6D5C6A7Q36836257-926D0278-4CDF-45CF-BBA2-0800B826A6A1Q36960910-279BB237-AD0F-4F98-A126-08F2B68CC11FQ37221074-10DD6F76-6FEA-4C2A-A16D-35D156D431CEQ37710874-465011B1-509E-4D08-B572-1399FCD0EE46Q38191293-F161E863-2C90-4EC0-87B8-7FDD9F56AFACQ38782290-8D6FD43C-D302-4D82-A5EE-8B7BB7BDBAE9Q38954524-4EB30D13-AF17-4C1C-88DA-0D565E5CAF45Q39294086-42ED5151-ECC0-49D8-928C-35F53C282C94Q49559280-A38D6753-7B1F-4C6B-8B5E-C56C144EC25BQ49620885-21352CEE-692E-4969-880C-219DB0DDF62AQ50063239-7ABFAF94-FB1D-4D1F-86EB-5101CBA9CEAEQ50352301-528BB8A5-43FD-4B50-BB3F-71FB38C29706Q51172142-A8FC471C-353F-4DAF-960D-27557F60D04FQ58779657-A452D7D9-880C-4FC8-BB65-E6F8A0CB77E8
P2860
MiR-382 targeting of kallikrein 5 contributes to renal inner medullary interstitial fibrosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
MiR-382 targeting of kallikrei ...... dullary interstitial fibrosis.
@ast
MiR-382 targeting of kallikrei ...... dullary interstitial fibrosis.
@en
type
label
MiR-382 targeting of kallikrei ...... dullary interstitial fibrosis.
@ast
MiR-382 targeting of kallikrei ...... dullary interstitial fibrosis.
@en
prefLabel
MiR-382 targeting of kallikrei ...... dullary interstitial fibrosis.
@ast
MiR-382 targeting of kallikrei ...... dullary interstitial fibrosis.
@en
P2093
P2860
P1476
MiR-382 targeting of kallikrei ...... dullary interstitial fibrosis.
@en
P2093
Alison J Kriegel
Brett Cohen
Kristie Usa
Mingyu Liang
Youhua Liu
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00173.2011
P577
2011-12-27T00:00:00Z